Tools for Checking Medicine Interactions

Increased Patient Role in Proposed Meaningful Use Stage II and III Recommendations

Monday, May 16, 2011 by Michelle Curren
Perhaps one of the biggest changes in the proposed Meaningful Use Stage II and III recommendations is the increase in interactions with the patient as well as the documentation it entails.  Some changes include: 
  • 30% of medication orders are to be tracked via an Electronic Medication Administration Record (EMAR)
  • Record 80% of patient demographics 
  • Patient specific educational resources - Stage 1 requires this for 10% of patients, Stage 2 is unchanged, and Stage 3 expands this to 20% in common specific languages.   
Patient education leaflets should help to improve the outcome of the patient as they continue their journey to recovery.  Finding a patient education leaflet in a patients native language may seem like a daunting task, yet with Lexicomp you are guaranteed a trusted source of patient education pamphlets available in 19 of the most commonly used languages in U.S. and Canada.  Another important feature is the ability to directly integrate Lexicomp's patient education materials into your HIS.

Looking for compatibility?

Thursday, May 12, 2011 by Michelle Curren
Compatability can easily make or break drug database decisions when choosing information for an EMR, EHR, or HIS.  Lexicomp's data is not only compatable with Oracle, SQL Server, MySQL, and Access, but also provides so much more.

Lexicomp can provide: 
  • A top of the line IT team that treats customers as partners
  • Specific clinical decision support functions, including drug-drug and drug-allergy interaction checking
  • Consumer-facing patient education materials
  • Compliancy with the RxNorm 
Contact Lexicomp today to find out all we have to offer!

How to Succeed in the Meaningful Use Marketplace?

Thursday, May 12, 2011 by Michelle Curren
Customers are the key to many successes, no matter what the industry.  This also includes EHR,  EMR, or HIS vendors.  
According to this survey, there are two major barriers to use of supporting information when e-prescribing: hard-to-use tools to view and import data into patient records, and data often not seen as useful enough to spend the extra time accessing.  So, satisfying this customer in this sense means being able to provide them with quality and easy to use information.  Lexicomp has been providing that to doctors worldwide for over 30 years.
Here is just some of what we have to offer:
  • Drug Interaction Data - we'll provide your system data that enables clinicians to screen for drug interactions, including drug-allergy, drug-drug and drug-food
  • RxNorm Mapping - we promote interoperability through mapping to industry standard RxNorm 
  • Drug Reference Data - integrate drug reference information, such as drug images and black box warnings, into your system
  • Patient Education Data - we provide patient education information that allows users to generate patient-specific handouts for medications (available in 19 languages), and conditions and procedures (available in English and Spanish)
  • Dose Range Checking - we provide data that enables clinicians to receive dosing alerts for medications, including limits for pediatric patients 
Make a choice that determines your success, make it Lexicomp.

Looking for easy implementation? We've got you covered.

Friday, April 29, 2011 by Michelle Curren
What is holding you back from easy implementation?  Perhaps you have a laundry list of items or perhaps money is constraint.  Either way, look to Lexicomp for an intuitive database design that will help you seamlessly integrate complex drug databases into your system.

Other items that Lexicomp can help check off your list:
  • Allows for specific clinical decision support functions, including drug-drug and drug-allergy interaction checking
  • Has consumer-facing patient education materials
  • Is compliant with the RxNorm 
  • Include comprehensive reference information for the US including drug generic name, drug brand name, drug classifications, and eventually clinical dosage guidelines for calculating pediatric and adult doses
So look around the market, investigate, but remember that Lexicomp can serve all your needs!

Ease Top Meaninful Use Concerns With Lexicomp

Wednesday, April 27, 2011 by Michelle Curren
According to a recent poll on iHealthBeat, "Health care CIOs who reported issues with achieving meaningful use, 28% said capturing and submitting quality data was their top concern, up from 22% of respondents to a similar poll in November 2010."  One way to ease this concern is to use excellent drug data as a base so there is quality from the beginning.

What does excellent entail?  Not necessarily price that's for sure.  One should look not for a supplier, but a partner that will work with you to achieve your goals.  An excellent drug database allows for: 
  • Data for drug-drug, drug-allergy and drug-disease interaction screening
  • Data to support duplicate therapy and dose range checking for pediatric and adult patients
  • Data that allows users to generate patient-specific education handouts

Talk to your partner and make sure your goals are aligned.  Also, make sure you are both on the same page about the meaning of excellent.

HITECH Act Drug Qualifications

Thursday, March 31, 2011 by Michelle Curren
Here are some of the qualifications that drug reference and drug interaction data must meet to qualify:
-- Must allow for specific clinical decision support functions, including drug-drug and drug-allergy interaction checking
-- Must have consumer-facing patient education materials
-- Must be compliant with the RxNorm (a medication list maintained by the National Library of Medicine)
-- Must include comprehensive reference information for the US including drug generic name, drug brand name, drug classifications, and eventually clinical dosage guidelines for calculating pediatric and adult doses

When looking for drug information that meets all these requirement, pick one that will partner with you to meet your needs, whether they be speed to market, budgetary, or customer service.  

This is what one of Lexicomp's satisfied customers has to say:

"We spent months researching and investigating the competition. Lexi-Comp business partnering and licensing division gave us the tools we needed to test it in our application to assure our clinicians that we had a reliable and trustworthy source. Their responsiveness to inquiries and requests sold us on a solid partnership we could count on."
- Coletta Dorado, CEO of IntuitivEMR

EHR Adoption Growth... Are you ready?

Tuesday, March 15, 2011 by Michelle Curren
According to a recent report from KLAS, "35% of all respondents are replacing their EHR systems and 43% of physician practices with more than 100 doctors are doing so."  What does that mean for EHR or EMR vendors? More sales, but only if you are ready.  What is keeping you from these customers?  If its drug data, then consider partnering with a trusted leader in drug databases for clinical decision support systems.  

Consider Lexicomp


Lexicomp can help by providing a medication list that includes both generic, brand name, and over-the-counter drugs. By providing drug interaction screening including drug-drug, dose range checking, and duplicate therapy screening, Lexicomp can help EHR vendors meet a number of Meaningful Use requirements.  The Lexi-Data product delivered by Lexicomp is also mapped to RXNORM and contains patient education which is another check box on the Meaningful Use requirements list.  

Predicted 50% Increase in EMR Adoption

Tuesday, March 15, 2011 by Michelle Curren
According to John at EMR and HIPPA, "My personal projection is that ONC should be really pleased if they achieve 50% EMR adoption by the end of the HITECH act (approximately 5 years). A number of really smart and involved people at HIMSS agreed with me on those numbers."

His other predictions include:
- Small practices have a much lower EMR adoption percentage as compared with large practices
- Specialists have a higher EMR adoption percentage than general medicine doctors

What is the best way to grab those small practices or specialists?
 
Make your EMR the most efficient and best value for them.  There are lots of things to consider when building an EMR, but drug information adds value no matter what.  Drug information is the foundation upon which safe decisions are made; decisions that involve pediatric dosage,  drug interaction, drug classifications,  and drug & medicine interactions.

Check out Lexicomp for this and more!

Patients and Meaningful Use

Monday, February 28, 2011 by Michelle Curren
Getting an EHR certified in meaningful use is supposed to have the end goal of improving the quality of patient outcomes.  A goal for Stage 2 is to make health information available for patients readily after their discharge.  Many hospitals are doing this through their websites, but how far are we from reaching those goals?  According to PwC's Health Research Institute report, putting patients into "meaningful use", not very close:
The PwC survey of 1,000 healthcare consumers found that:
  • Half of patients said they call their physician's office or hospital for a paper record, and 11% said they don't know how to get their health record.
  • Of those who access their medical record electronically, 34% share the information with primary care physicians and specialists.
  • Only 13% of consumers said they'd been asked by providers what they think about EMRs, even though 56% said they'd be willing to talk about what they'd like in an EMR and how they'd like to use it.
What should you be doing to accomplish these goals?  A good first step is to put quality, easy to read drug information in the hands of patients.  Lexicomp not only provides the drug information needed by clinicians when treating patients, but also provides patient focused drug information that is written for the patient.  Hospitals can provide this information through their site.  Medication leaflets in up to 19 languages, patient level drug interaction analysis, and lists of medications by brand and generic.  All this information can provide patients that extra needed value from your hospital to make them feel better about their experience and Lexicomp can provide the consumer information needed to build that site.  

Mom always said, "Do it right the first time and you won't have to do it again."

Friday, February 18, 2011 by Michelle Curren
As the case would be, she was right (along with many other things).  This lesson applies not only to life, but also to EMR vendors who just read the blog post.  

How can you ensure that you are using trusted, valid, accurate information to do it right? Research, partnerships, trust, testimonials, and the test of time are all crucial elements to picking any information provider, but especially the drug information.  Drug information plays such a key role in any EMR that this is one area where a "do over" will not be allowed in the marketplace.  Ensure you are getting the best the first time around.

Lexicomp is one of the few that have the best information.  We have also been in business for over 30 years.  We treat our clients as partners; your success is our success.  Just read what others are saying.  So if you need pediatric dosage calculations, drug interaction software, drug and medicine interactions, or clinical information systems,  come see us at HIMSS 2011 at booth #6653!

More Reasons to Go the Extra Mile with an Excellent Drug Database

Friday, February 18, 2011 by Michelle Curren
A recent post of mine mentioned that EMR vendors should be going the extra mile or two beyond meaningful use requirements.  After learning how meaningful use incentive dollars may be on the GOP chopping block, this post rings true more than ever.  At the end of the day hospitals want the MU dollars, but if they are no longer available, they will need an EMR that provides ROI in other ways.
When thinking about the development and end use of the EMR, patients are key.  One way to increase ROI is to ensure patient safety and satisfaction.   

The solution?  An excellent drug database.  

What does excellent entail?  An excellent drug database allows for: 
  • Data for drug-drug, drug-allergy and drug-disease interaction screening
  • Data to support duplicate therapy and dose range checking for pediatric and adult patients
  • Data that allows users to generate patient-specific education handouts
Lexicomp is one of the few providers of an excellent drug database.  Come find out more at HIMSS 2011 at the Lexicomp booth #6653 or click here!

EMR Spending to Double...get your slice of the pie!

Friday, February 18, 2011 by Michelle Curren
According to a recent article from American Medical News, "Total EMR spending, which is expected to grow from $1.9 billion in 2009 to $3.8 billion by 2015, is about twice the growth rate analysts are seeing over the health information technology market and the general IT market, said Judy Hanover, research director of provider IT strategies for the Framingham, Mass.-based market research company and co-author of the report."

What is the best way to ensure more clients?  Make your EMR the most efficient and best value for them.  There are lots of things to consider when building an EMR, but drug information adds value no matter what.  Drug information is the foundation upon which safe decisions are made; decisions that involve pediatric dosages, drug classifications, drug and medicine interactions, and medicine lists.
If you happen to be in Orlando next week, be sure to stop by booth #6653 to learn more about a great drug database provider.

Going the extra mile..or two

Tuesday, February 1, 2011 by Michelle Curren
 If you are building or purchasing an EHR with plans to meet meaningful use, why not consider going beyond the requirements?
 
Some reasons to do so may include:
  • The Rules are Not Written in Stone: with the Stage 2 of meaningful use requirements out recently, the urgency of drug-drug and drug-allergy interaction checking has increased.  Companies need to be prepared to meeting meaningful use and then some to stay abreast to the changes.
  • More options to integrate EHR into day to day hospital operations.  A recent Healthcare IT News article shows how both the Bon Secours Health System and Geisinger Health System will be reaching above the meaningful use requirements to "move toward care coordination in the real world"
When looking for a drug vendor it only makes sense, then, to seek one that has the capability and support to move above the meaningful use threshold.  

Lexicomp's drug references are ready for that task.  There is also unique content not available elsewhere, like Lexicomp’s industry-leading Pediatric Dose Range Checking.  Come learn more about Lexicomp and what they can provide at HIMSS 2011 show in Orlando, Florida February 21 - 23!

Investing Money into Meaningful Use: Know what to look for!

Sunday, January 30, 2011 by Michelle Curren
 A report posted January 21, 2011 by iHealthBeat states, "Nearly 90% of U.S. hospitals will need to install or upgrade their electronic health record systems during the next three years to comply with the federal government's meaningful use requirements."  Hospitals have the option to purchase a "ready made" from a vendor or to make their own.  No matter what the case, be sure your drug information complies with meaningful use.  While you are at, you might as well go above the requirements. 
 
There are several components to look for drug information:dose range checking,  pediatric dosing, drug calculators, medicine interactions, dosage precautions, clinical guidelines, drug interaction software, duplicate therapy, drug classifications, generic drug names, drug nomenclature and more.  These are critical paths for an EMR build.  But it's not just about the information.  It's about who you select as your partner and who have seamless APIs which makes your drop easier.  

Meeting with these vendors in person may help in picking the right partner.  The HIMSS 2011 show in Orlando, Florida February 21 - 23 will showcase many of these partners, Lexicomp included!   

More Indication of Growth in the EHR Marketplace

Tuesday, January 11, 2011 by Michelle Curren
Last Monday I posted that there was opportunity for a piece of the growing EHR marketplace with 4,000 companies jumping to start the registration process.  Another sign of growth has been reported today by HealthData Management.  According to a recent posting, "U.S. market for inpatient and outpatient electronic health records software was nearly $1.98 billion in 2009 and will steadily increase to $3.8 billion in 2015" as found in a new report by the research firm IDC Health Insights, Framingham, Mass.
 
These numbers can be further broken down in Ambulatory and Inpatient EHR electronic records software spending.  Ambulatory EHR Spending by all types of providers totaled $633.5 million in 2009, rising in 2015 to $1.41 billion.  Inpatient EHR Spending was $1.34 billion in 2009, rising in 2015 to about $2.4 billion.
 
With all this money being spent and more to come, it's not too late to get your software on the certification track with trusted drug data.  Don't wait until the end of your development process to worry about:  dose range checking,  pediatric dosing, drug calculators, medicine interactions, dosage precautions, clinical guidelines, drug interaction software, duplicate therapy, drug classifications, generic drug names, drug nomenclature and more.  These are critical paths for an EMR build.  But it's not just about the information.  It's about who you select as your partner and who have seamless APIs which makes your job easier.   
 
You owe it to your product and your customer to make the right choice.  

4,000 Health Care Provides Register for Incentive Payments. Do you have a piece of that pie?

Monday, January 10, 2011 by Michelle Curren
According to the Government Health IT, as of January 6 there have been 4,000 healthcare providers that have registered for the EHR incentive program.  Also, according to the Centers for Medicare and Medicaid Services spokesman, Joseph Kuchler, “We expect that number will continue to increase daily.”   With as many as 4,000 already started the registration process and more to follow, there are lots of opportunities to gain business.  What will make your EHR stand out from the crowd?
 
Healthcare providers that need a complete EHR are looking for drug data that will enhance and improve patient safety.  What better drug information than from a trusted company that's been developing content for over 30 years?  Not only will Lexicomp  provide all the basic drug data information such as:  drug interactions;  drug-allergy interactions,  therapeutic dosages,  drug classifications, dosage administration,  pediatric drug information,  and more;  but Lexicomp will also provide the service and support to allow you to move quickly in the fast paced environment.

Better alerts are needed for increased medical performance!

Wednesday, December 29, 2010 by Michelle Curren
In a recent study published by the journal, Medical Care, hospitals using a EHR that alerted physicians to possible problems helped to improve overall patient outcomes, including:
  • The percentage of heart disease patients receiving cholesterol-lowering medications rose from 87% to 93%
  • The percentage of patients receiving pneumonia vaccinations increased from 80% to 90%
 
Although many of our other posts warn against alert fatigue or too many alerts.  What is the solution?  Alerts need to be meaningful to the people using them.  Electronic health record (EHR) and other healthcare information system vendors need smart, current drug data that will enable their systems to drive patient safety and improve healthcare -- without generating a flood of annoying alerts that will only be ignored. 
 
Lexi-Data is the foundation of Lexi-Comp's clinical decision support architecture. This product provides information that can drive relevant patient-specific alerts and referential content to support sound treatment decisions in areas such as drug interaction checking (drug-drug and drug-food), drug allergy checking, therapeutic duplication checking, dose range checking (adult and pediatric) and more. 
 

Top Health Industry Issues of 2011

Friday, December 24, 2010 by Michelle Curren
 In a recent report by PricewaterhouseCoopers Health Research Institute, CQ, it found that health care providers spent more than $88.6 billion in 2010 to implement EHR systems and other health IT projects.  Are you an EHR company looking to get a piece of that $88 billion?  If so, Lexicomp can help you get your EHR system to the market faster and with better data for clinical decision support.  Whether you are seeking drug databases, drug nomenclature, duplicate therapy checking, or dosage range checking capabilities, Lexicomp has your solution. Contact Lexicomp today and you'll be one step closer to launching your EHR system!
 
 

Is Meaningful Use a Top Priority?

Friday, December 3, 2010 by Michelle Curren
According to a Computer Sciences Corp survey posted by Fierce EMR, "90 percent of hospital executives count achieving Meaningful Use of EMR among their top two priorities."  If you are part of this 90%, what are you doing to ensure your EMR's Meaningful Use Certification?  A key factor to achieving certification is trusted, reliable, easy to use drug information.  When you implement Lexi-Comp’s drug data and reference information, you will be one step closer to checking Meaningful Use off your list!
 
Lexi-Comp provides:
-Data for drug-drug, drug-allergy and drug-disease interaction screening
-Data to support duplicate therapy and dose range checking for pediatric and adult patients
-Data that allows users to generate patient-specific education handouts
 
New in November 2010! Lexi-Comp can help your EMR meet ONC’s “Submission to Immunization Registries” standard!  We’ll provide you immunization-specific data (CVX and MVX codes) that enables healthcare providers and end users to electronically transmit a patient’s vaccination history to an official registry.

How Lexi-Comp can meet your needs

Tuesday, November 9, 2010 by Michelle Curren
According to a study by CompTIA, doctors have reported wanting EMR/EHR systems that are:
 
1. Faster
Lexi-Data enables swiftness through meaningful clinical alerts backed by information that provides them to context to make the right decisions for better patient outcomes.
 
2. Easier to use
Lexi-Comp makes your system easier to use because our dedicated customer support works with you as a partner, aimed at solving your problems and ensuring you are completely satisfied.  

This is what one of our satisfied customers has to say: "We spent months researching and investigating the competition. Lexi-Comp business partnering and licensing division gave us the tools we needed to test it in our application to assure our clinicians that we had a reliable and trustworthy source. Their responsiveness to inquiries and requests sold us on a solid partnership we could count on."
- Coletta Dorado, CEO of IntuitivEMR
 
3. Have better interoperability 
Delivery options include database tables that are compatible with Oracle®, SQL Server®, and MySQL® and an easily implemented Software Development Kit (SDK) powered by Java™ or .NET APIs.
 
4. Cost less
When you use Lexi-Comp's drug information you are ensuring the best drug database and drug nomenclature contained within the system.  In addition, updates provide you with the most most current drug product and clinical information available.  There will be no worries or costly mistakes that may come from building your own.  Also, remember you may end up spending just as much money developing your own EMR system as you will spend by purchasing a solution from a content vendor like Lexi-Comp.